VANCOUVER, BC, Dec. 12, 2022 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest, Founder and CEO of Numinus, will present at the KCSA Mental Health Investor Conference to be held at…

Source

Previous articleThinking Beyond Set and Setting in the Psychedelic Experience
Next articleIsrael- Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute